ISC 2020 Stroke News Day (2)

3 THURSDAY , FEBRUARY 20, 2020 STROKE NEWS #ISC20 Today at Sessions TOP PICKS FROM THE PROGRAM CHAIR Miguel Perez-Pinzon, PhD, FAHA I hope you’re enjoying your time in Los Angeles and visiting with your colleagues from around the world. Today rounds out Day 2 of exceptional programming. Here are my top picks for today and tomorrow: TOP PICK NO. 1 Thursday’s Main Event: I encourage you to attend today’s Main Event because we have an exceptional Thomas Willis Lecture. Danish neuroscientist Maiken Nedergaard, MD, will explore whether the glymphatic system plays a role in ischemic edema. You’ll also hear the results of five late-breaking science abstracts. (See the list of Late-Breaking Science presented today and tomorrow in the box on the right side of this page.) Plus, we’ll present the ISC Outstanding Stroke Research Mentor Award. (10:30 a.m. Thursday in Hall K) TOP PICK NO. 2 Telestroke: In this last decade, telestroke has increased tPA access and shortened door-to-treatment time for patients with acute stroke. “Widening the Lens of Telestroke: From the ED Across the Stroke Continuum” will explore the benefits of expanding telestroke services beyond the emergency department. (1:30 p.m. Thursday in Room 151) TOP PICK NO. 3 Brain Health: New this year is the Brain Health Track. Seven sessions beginning Thursday morning and continuing Friday will explore elements of cognition, the role of genes, adaptive myelination, subclinical cerebrovascular disease imaging biomarkers and more. (Check your mobile app for details, times and locations.) TOP PICK NO. 4 Posters: Be sure to visit the Poster Hall, Hall H, adjacent to the Science & Technology Hall, to see some of the exciting research being conducted. Please refer to the Poster Hall Map in your program for more information. Moderated Poster Sessions will be held from 5:30 to 6:30 p.m. and Regular Poster Sessions from 6:30 to 7 p.m. Please support your colleagues by attending this important event. TOP PICK NO. 5 Closing Main Event: Be sure to check out the Late-Breaking Science (see box at right) and two key lectures (see below) during Friday’s Closing Main Event. David G. Sherman Lecture “Comprehensive Stroke Care and Outcomes: Is It Time for a Paradigm Shift?” Pamela W. Duncan, Winston-Salem, North Carolina WilliamM. Feinberg Lecture “Stroke Prevention: A Lifetime of Lessons” J. David Spence, London, Ontario, Canada Don’t miss your chance to visit the Science & Technology Hall! 10 a.m.-4 p.m. Thursday LATE-BREAKING SCIENCE Check the AHA Conferences app to verify times and locations. Tweet your questions/ comments or talk about what’s happening at ISC 2020. Use hashtag: #ISC20 . Follow ISC on Twitter Be sure to stop by HEADQUARTERS, Booth 155 for all things ISC 2020. Giveaways available while supplies last. Stroke News is produced for the American Heart Association/ American Stroke Association’s International Stroke Conference by Ascend Media, LLC ( ). Paid advertisements are not reviewed by the AHA for scientific accuracy. ©2020 by the American Heart Association/American Stroke Association 7272 Greenville Avenue, Dallas, TX 75231 1-888-4-STROKE After you have read this issue of Stroke News , please share with colleagues or deposit it in an approved paper recycling bin. Yvette Ballantyne, MA Senior Manager, International Stroke Conference Roger Campbell Senior Writer/Editor, Content and Editorial Anne Leonard, MPH, RN, CCRC Senior Science and Medicine Advisor THURSDAY 11 a.m.-Noon • Determining the Optimal Dose of Tenecteplase Before Endovascular Thrombectomy (EXTEND-IA TNK Part 2): A Multicenter, Randomized, Controlled Trial • ESCAPE-NA1 Trial • Multifocal Transcranial Rotating Permanent Magnet Stimulation in Chronic Ischemic Stroke • The Woven Study: Wingspan One-Year Vascular Imaging, Events and Neurologic Outcomes • Effects of Pre-Hospital Acute Stroke Treatment as Measured With the Modified Rankin Scale: The Berlin — Pre-Hospital or Usual Care Delivery (B_PROUD) Trial CLOSINGMAIN EVENT FRIDAY 10:30 a.m.-12:30 p.m. • The Randomized Study of Endovascular Therapy With Versus Without Intravenous Tissue Plasminogen Activator in Acute Stroke With ICA and M1 Occlusion (SKIP Study) • Comparative Effectiveness of Home BP Telemonitoring Plus Nurse Case Management (HBPTM+NCM) Versus HBPTM Alone on Systolic BP (SBP) Reduction Among Minority Stroke Survivors • The Spot Sign and Tranexamic Acid on Preventing ICH Growth — Australasia Trial (STOP-AUST): A Multicenter, Randomized, Double-Blind, Placebo- Controlled Trial • Cilostazol Versus Other Anti-Platelet Drugs for the In-Stent Restenosis After Carotid Artery Stenting: The Carotid Artery Stenting With Cilostazol Addition for Restenosis (CAS-CARE) Trial • Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or PCI in Patients With Atrial Fibrillation and Prior Stroke: Insights From the AUGUSTUS Trial • World’s First Robotic Neurovascular Intervention Experience: Opening the Doors to Remote Procedures